Nektar Therapeutics
NKTR
NKTR
138 hedge funds and large institutions have $1.4B invested in Nektar Therapeutics in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 69 increasing their positions, 35 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
+2
Holders Change %
+1.47%
% of All Funds
3.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
69
Reduced
35
Closed
16
Calls
$7.03M
Puts
$5.15M
Net Calls
+$1.88M
Net Calls Change
+$2.03M
Top Buyers
| 1 |
Primecap Management
Pasadena,
California
|
+$36.8M |
| 2 |
JPMorgan Chase & Co
New York
|
+$33.3M |
| 3 |
O
OppenheimerFunds
New York
|
+$17M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$13.7M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$9.22M |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$6.11M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.15M |
| 3 |
AG
Artal Group
Luxembourg
|
-$3.64M |
| 4 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$3.45M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$2.28M |
